Compare LBRDA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LBRDA | RGEN |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United States | United States |
| Employees | 1900 | N/A |
| Industry | Cable & Other Pay Television Services | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 6.6B |
| IPO Year | N/A | 1995 |
| Metric | LBRDA | RGEN |
|---|---|---|
| Price | $52.63 | $122.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $172.91 |
| AVG Volume (30 Days) | 150.0K | ★ 768.4K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.86 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | N/A | $14.30 |
| Revenue Next Year | $109.28 | $14.52 |
| P/E Ratio | ★ $8.39 | $139.72 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $42.05 | $109.66 |
| 52 Week High | $100.85 | $175.77 |
| Indicator | LBRDA | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 57.34 | 53.95 |
| Support Level | $51.95 | $121.25 |
| Resistance Level | $55.15 | $130.56 |
| Average True Range (ATR) | 1.73 | 4.59 |
| MACD | 0.22 | 1.72 |
| Stochastic Oscillator | 97.13 | 98.50 |
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services, including video, internet, voice, and mobile services; commercial services, including small and medium business and enterprise solutions; advertising services; and other services. The company's reportable segments are GCI Holdings and Charter. The firm derives the majority of its revenue from GCI Holdings.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.